Kit for detecting SNP (Single Nucleotide Polymorphism) sites related to Warfarin individualized application, and multiplex PCR (Polymerase Chain Reaction) amplification method and detection method using same

A kit and site technology, applied in biochemical equipment and methods, microbial determination/inspection, etc., can solve the problems of decreased arachidonic acid metabolism, decreased CYP4F2 enzymatic activity, decreased arachidonic acid production, etc. , to achieve the effect of reducing detection cost and operation complexity, reducing operation steps and avoiding aerosol pollution

Inactive Publication Date: 2011-11-23
UNION STEMCELL & GENE ENG +1
View PDF2 Cites 24 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] CYP4F2 is the main metabolic enzyme that metabolizes arachidonic acid to produce tetraenoic acid. Recently, a V433M mutation in the CYP4F2 gene was found to reduce the metabolic capacity of arachidonic acid and reduce the production of tetraenoic acid. Enzymatic activity of CYP4F2
CYP4F2 is a monooxygenase of vitamin K, which can oxidize substrates to generate ω-hydroxyl derivatives, and different genotype

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for detecting SNP (Single Nucleotide Polymorphism) sites related to Warfarin individualized application, and multiplex PCR (Polymerase Chain Reaction) amplification method and detection method using same
  • Kit for detecting SNP (Single Nucleotide Polymorphism) sites related to Warfarin individualized application, and multiplex PCR (Polymerase Chain Reaction) amplification method and detection method using same
  • Kit for detecting SNP (Single Nucleotide Polymorphism) sites related to Warfarin individualized application, and multiplex PCR (Polymerase Chain Reaction) amplification method and detection method using same

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0067] Example 1

[0068] Step 1: Preparation of Whole Blood Cell Lysate

[0069] Take 300 μl of peripheral venous blood of the subject, add 700 μl of cell lysate, invert and mix 5 times, centrifuge at 12,000 rpm for 1 minute, discard the supernatant, and place the centrifuge tube upside down on clean absorbent paper for 2 minutes to ensure that the pellet is in the tube , add 300 μl of double-distilled water, and mix by vortexing to form a cell lysis suspension.

[0070] Step 2: PCR Amplification Reaction

[0071] 1. Configure the wild-type reaction system: add 4.8 μl of cell lysis suspension, 5 μl of 2× wild-type amplification buffer and 0.2 μl of polymerase (2.5U / μl) into the PCR tube to form an independent reaction system. Homogenize, centrifuge briefly, and finally gently add 20 μl of liquid paraffin oil along the tube wall to seal the system, as shown in the following table:

[0072] 2x wild-type amplification buffer

[0073] 2. Configure the mutant reaction...

Example Embodiment

[0087] Embodiment 2

[0088] Step 1: Extraction and Dilution of Whole Blood Genomic DNA

[0089] Take 300 μl of peripheral venous blood of the subject, and extract whole blood genomic DNA according to the instructions of the whole blood genomic DNA extraction kit. Measure the concentration of DNA with a spectrophotometer and dilute to 15-20 ng / μl.

[0090] Step 2: PCR Amplification Reaction

[0091] 1. Configure the wild-type reaction system: add 4.8 μl of cell lysis suspension, 5 μl of 2× wild-type amplification buffer and 0.2 μl of polymerase (2.5U / μl) into the PCR tube to form an independent reaction system. Homogenize, centrifuge briefly, and finally gently add 20 μl of liquid paraffin oil along the tube wall to seal the system, as shown in the following table:

[0092] 2x wild-type amplification buffer

[0093] 2. Configure the mutant reaction system: add 4.8 μl of cell lysis suspension, 5 μl 2× mutant amplification buffer and 0.2 polymerase (2.5 U / μl) to the P...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a kit for detecting SNP (Single Nucleotide Polymorphism) sites related to Warfarin individualized application by combining multiplex PCR (Polymerase Chain Reaction) technology and SNP sensitive molecule switch technology and a detection method using the same. The kit types four SNP sites related to Warfarin application, including rs9934438 SNP site on VKORC1 gene, rs1799853 and rs1057910 SNP sites on CYP2C9 gene, and rs2108622 SNP site on CYP4F2 gene. The kit comprises a wild type 2*amplification buffer, a mutant type 2*amplification buffer, polymerase, a cell lysis solution and glycerol, wherein the two buffers respectively contain corresponding SNP wild type and mutant phenotype sequence specific primers and beta-actin primers; and the four SNP sites can be typed in the two multiplex PCR reactions, thereby providing molecular biology references for reasonable application of Warfarin.

Description

technical field [0001] The invention relates to a kit for detecting SNP sites and a PCR amplification method thereof, in particular to a kit for detecting SNP sites related to warfarin individualized medication and a multiplex PCR amplification method thereof using multiplex PCR combined with molecular switch technology Detection method. Background technique [0002] Warfarin is a dicoumarin-based oral anticoagulant that inhibits the synthesis of coagulation factors II, VII, IX, and X by vitamin K in liver cells, thereby exerting an anticoagulant effect. It is mainly used clinically to prevent and treat thromboembolic diseases, such as treating thromboembolic phlebitis, reducing the morbidity and mortality of pulmonary embolism, and reducing venous thrombosis in major surgical operations, such as hip arthrodesis and artificial heart valve replacement. Incidence, and as an adjuvant drug for myocardial infarction. However, the effective therapeutic range of warfarin is narro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/68
Inventor 韩俊领杜宏伟周毓玲崔丽娟
Owner UNION STEMCELL & GENE ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap